NF-kappaB Signaling Networks in I/R and Late PC
I/R 和晚期 PC 中的 NF-kappaB 信令网络
基本信息
- 批准号:7072310
- 负责人:
- 金额:$ 37.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-07-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:apoptosisbiological signal transductioncardiac myocyteschromatin immunoprecipitationcytokinecytoprotectiongene expressiongenetic regulationgenetic regulatory elementgenetically modified animalshistopathologyintermolecular interactionlaboratory mousemicroarray technologymitogen activated protein kinasemolecular pathologymyocardial ischemia /hypoxianitric oxide synthasenuclear factor kappa betaphosphorylationposttranslational modificationsprostaglandin endoperoxide synthaseprotein structure functiontumor necrosis factor alphawestern blottings
项目摘要
Clinical and basic science studies demonstrate that nuclear factor-kappaB (NF-kappaB) is activated after ischemia/reperfusion (I/R) and is positively correlated with increased morbidity and mortality in patients with unstable angina. Although we have shown that the overall effect of NF-kappaB in the heart after I/R is injurious, NF-kappaB is capable of activating cell-survival/growth factors and genes associated with cardioprotective and anti-apoptotic effects as well as genes associated with inflammation and apoptotic cell death. Yet there is little understanding of how antithetical pathophysiological processes are regulated by different and possibly overlapping sets of NF-kappaB-dependent genes. The goal of this proposal is to delineate the mechanisms by which NF-kappaB contributes to ischemia/reperfusion injury on one hand and the cardioprotective effects of late ischemic PC on the other. The central hypothesis is that NF-kappaB is a key integrator of multiple signaling pathways, including cytokines and mitogen-activated protein kinases (MAPK), and acts, via regulation of NF-kappaB-dependent genes, to influence cell death/survival after I/R and during development of late PC. This hypothesis is based upon Preliminary Results that genetic blockade of NF-kappaB affects I/R injury and abrogates the protective effects of late PC against MI in association with modulation of critical genes including iNOS, Cox2, HSP70 and metallothionein. The specific Aims of the proposal are:
Aim 1. Determine the role of NF-kappaB-dependent gene expression in I/R injury and late ischemic PC.
Aim 2. Delineate the signaling pathways that activate NF-kappaB and the key cross-talk interactions that occur post-I/R and after late ischemic PC.
Aim 3. Determine the transcriptional mechanism by which NF-kappaB affects gene expression to
evoke cell death after I/R and cardioprotection consequent to late ischemic PC.
This proposal is innovative in that it addresses a novel concept; that NF-kappaB acts as a signaling integrator or "hub" that affects cardiac pathophysiology by the integrative regulation of NF-kappaB-dependent genes. The expected contribution of the research is attainment of new knowledge regarding the mechanism by which NF-kappaB-dependent gene expression mediates I/R injury and evokes the cardioprotective effects of late PC. This is significant because a mechanistic understanding is necessary to develop strategies to block NF-kappaB and specific sets of NF-kappaB-dependent genes for the development of novel therapeutic regimens that maximize the beneficial effects while limiting the deleterious effects of NF-kappaB signaling.
临床和基础科学研究表明,核因子-KAPPAB(NF-kappab)在缺血/再灌注后激活(I/R),并且与不稳定的心绞痛患者的发病率和死亡率呈正相关。尽管我们已经表明,I/R后NF-kappab在心脏中的总体作用是有害的,但NF-kappab能够激活与心脏保护和抗凋亡效应以及与炎症和肿瘤细胞死亡相关的基因以及基因相关的细胞生存/生长因子和基因。然而,几乎没有什么了解对立的病理生理过程如何受到不同且可能重叠的NF-kappab依赖性基因的调节。该提案的目的是描述NF-kappab一方面有助于缺血/再灌注损伤的机制,以及晚期缺血性PC对另一方面的心脏保护作用。中心假设是NF-kappab是多个信号通路的关键集成剂,包括细胞因子和有丝分裂原激活的蛋白激酶(MAPK)(MAPK),以及通过调节NF-kappab依赖性基因的调节,以影响I/R和PC后期PC发育后的细胞死亡/生存。该假设是基于初步结果,即NF-kappab的遗传阻断会影响I/R损伤,并消除了晚期PC对MI的保护作用,并与包括Inos,Cox2,HSP70和金属硫蛋白在内的关键基因的调节有关。该提案的具体目的是:
AIM 1。确定NF-kappab依赖性基因表达在I/R损伤和晚期缺血PC中的作用。
AIM 2。描述激活NF-kappab的信号通路以及在I/R之后以及晚期缺血性PC之后发生的关键交叉对话相互作用。
目标3。确定nF-kappab影响基因表达的转录机制
I/R和心脏保护后唤起细胞死亡,导致晚期缺血性PC。
该提议具有创新性,因为它解决了一个新颖的概念。 NF-kappab充当信号积分或“枢纽”,通过NF-kappab依赖性基因的整合调节影响心脏病理生理。这项研究的预期贡献是获得有关NF-KAPPAB依赖性基因表达介导I/R损伤并唤起PC后期PC的心脏保护作用的新知识的新知识。这很重要,因为对于制定阻止NF-kappab的策略和特定的NF-kappab依赖性基因,对于开发新型治疗方案的策略是必要的,从而最大程度地提高了有益效果,同时限制了NF-kappab信号的有害影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Walter Keith Jones其他文献
Walter Keith Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Walter Keith Jones', 18)}}的其他基金
Paradoxical Effects of NF-kB in Ischemia; Novel Polymeric Gene Silencing in vivo
NF-kB 在缺血中的矛盾作用;
- 批准号:
7820969 - 财政年份:2009
- 资助金额:
$ 37.47万 - 项目类别:
Paradoxical Effects of NF-kB in Ischemia; Novel Polymeric Gene Silencing in vivo
NF-kB 在缺血中的矛盾作用;
- 批准号:
8077319 - 财政年份:2008
- 资助金额:
$ 37.47万 - 项目类别:
Paradoxical Effects of NF-kB in Ischemia; Novel Polymeric Gene Silencing in vivo
NF-kB 在缺血中的矛盾作用;
- 批准号:
7658683 - 财政年份:2008
- 资助金额:
$ 37.47万 - 项目类别:
Paradoxical Effects of NF-kB in Ischemia; Novel Polymeric Gene Silencing in vivo
NF-kB 在缺血中的矛盾作用;
- 批准号:
7882702 - 财政年份:2008
- 资助金额:
$ 37.47万 - 项目类别:
NF-kappaB Signaling Networks in I/R and Late PC
I/R 和晚期 PC 中的 NF-kappaB 信令网络
- 批准号:
7244997 - 财政年份:1999
- 资助金额:
$ 37.47万 - 项目类别:
NITRIC OXIDE (NO) DEPENDENT ACTIVATION OF INOS IN LATE P
P 晚期 INOS 的一氧化氮 (NO) 依赖性激活
- 批准号:
6607114 - 财政年份:1999
- 资助金额:
$ 37.47万 - 项目类别:
NF-kappaB Signaling Networks in I/R and Late PC
I/R 和晚期 PC 中的 NF-kappaB 信令网络
- 批准号:
6914998 - 财政年份:1999
- 资助金额:
$ 37.47万 - 项目类别:
NITRIC OXIDE (NO) DEPENDENT ACTIVATION OF INOS IN LATE P
P 晚期 INOS 的一氧化氮 (NO) 依赖性激活
- 批准号:
2884177 - 财政年份:1999
- 资助金额:
$ 37.47万 - 项目类别:
NITRIC OXIDE (NO) DEPENDENT ACTIVATION OF INOS IN LATE P
P 晚期 INOS 的一氧化氮 (NO) 依赖性激活
- 批准号:
6700441 - 财政年份:1999
- 资助金额:
$ 37.47万 - 项目类别:
NITRIC OXIDE (NO) DEPENDENT ACTIVATION OF INOS IN LATE P
P 晚期 INOS 的一氧化氮 (NO) 依赖性激活
- 批准号:
6390420 - 财政年份:1999
- 资助金额:
$ 37.47万 - 项目类别:
相似国自然基金
硫化氢抑制采后枸杞乙烯生物合成及其信号转导的机理研究
- 批准号:32360612
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
生物钟核心转录因子PRRs调控JA信号转导及植物对灰霉菌防御的分子机理
- 批准号:32370606
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于“丛枝菌根真菌-激素信号转导-转录因子-L/ODC基因”调控路径解析苦参生物碱生物合成的调控机制
- 批准号:82304678
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
- 批准号:82370988
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
新型信号转导光电化学免疫生物传感对肝癌相关分子标志物检测新方法研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 37.47万 - 项目类别:
Determinants of cardioprotection by circulating prohibitin-1 during sepsis
败血症期间循环抑制素 1 的心脏保护作用的决定因素
- 批准号:
10577340 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
Novel Inhibitors for Temporal Modulation of T-Lymphocytes during Chronic Heart Failure
慢性心力衰竭期间 T 淋巴细胞时间调节的新型抑制剂
- 批准号:
10638340 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
Identifying Novel Signaling Mechanisms Downstream of Cardiac Gq-Coupled Receptors
鉴定心脏 Gq 偶联受体下游的新型信号传导机制
- 批准号:
10535591 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
Role of eosinophil cationic proteins in cardiac hypertrophy
嗜酸性粒细胞阳离子蛋白在心脏肥大中的作用
- 批准号:
10735136 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别: